Trade Novavax NVAX

Sell
 Buy

Novavax live chart

5m 15m 30m 1h 4h 1d 1w

Instrument Fundamentals

Weekly Search
Weekly
Daily
Date Close change Change (%) Open High Low

Novavax news

2021 May 11, 13:20

US pre-market: selling unabated

2021 May 06, 08:27

Stocks rally as Fed speakers get back on script, earnings support + Bank of England set to raise forecasts

2021 Feb 28, 07:36

Week Ahead: RBA speaks, US NFPs released & OPEC clash

2020 May 26, 08:04

Leg up: stocks make new ground, travel stocks soar

Latest news

Show more
Frances Wang 2025 May 21, 16:00

What is the TQQQ ETF: What are the risks associated with TQQQ ETF?

ETFs
Tommy Yap 2025 May 21, 16:00

Morning Note: Nvidia Slams China Chip Ban; Bitcoin Climbs on Trade Peace;

Morning Note Tech Cryptocurrencies
Tommy Yap 2025 May 21, 16:00

Morning Note: UK Inflation Surprises Higher; Mideast Tensions Fuel Oil, Gold

Morning Note Commodities
Frances Wang 2025 May 20, 16:00

Palantir Stock Price Analysis: What is the prediction for PLTR?

Stocks
Frances Wang 2025 May 19, 16:00

Stock index news today: ASX 200 goes higher on RBA Rate Cut

Indices
Tommy Yap 2025 May 19, 16:00

Morning Note: RBA Eases Policy; Canada's Inflation Outlook; China Lowers Rates

Morning Note AUD CAD China
Tommy Yap 2025 May 19, 16:00

Morning Note: ECB Easing May Pause; Japan's Economic Slump; US Credit Caution

Morning Note
Frances Wang 2025 May 18, 16:00

Forex market today: India's Forex Reserves Hit 7-Month High

Forex

Info

Spread

0.06

Spread (%)

0.8368 %

Leverage

1:10

Overnight Interest Buy

-0.0597 %

Overnight Interest Sell

-0.0292 %

Currency

USD

Trading Hours

Market open

Thursday

13:31 - 19:59

Tuesday

13:31-19:59

Wednesday

13:31-19:59

Friday

13:31-19:59

Analysis and statistics

Open

---

Previous Close

---

52 Week High/Low

--- – ---

Market cap

1151606784

Shares Outstanding

161970000

Earnings Date (Next)

2019-05-10

instr__dividend_date

2019-05-10

instr__ex_dividend_date

instr__forward_annual_dividend_rate

0

instr__forward_annual_dividend_yield

0

EPS

2.75

Learn more about this instrument

Novavax Novavax Inc
Novavax, Inc., a biotechnology company, engages in the discovering, developing, and commercializing vaccines to protect against serious infectious diseases in the United States, Europe, and internationally. The company offers vaccine platform that combines a recombinant protein approach, nanoparticle technology, and its patented Matrix-M adjuvant to enhance the immune response. The company is commercializing a COVID-19 vaccine, NVX-CoV2373 under the brand names of Nuvaxovid, Covovax, and Novavax COVID-19 Vaccine, adjuvanted for adult and adolescent populations as a primary series and for both homologous and heterologous booster indications. It also developing R21/Matrix-M adjuvant malaria vaccine. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.
Markets.com Bonus Trading

Related Instruments

Asset
Sell
Buy
Change (%)

Trade Now

Trade Now

Trade Now

Trade Now
View all instruments

Latest Education Articles

Show more
Markets.com Bonus Trading
Trustpilot